Curbside Consults Immune Checkpoint Inhibitors with Dr. Kerry Reynolds
Jul 17, 2023
Dr. Kerry Reynolds, Clinical Director of Inpatient Oncology at Massachusetts General Hospital, discusses immune checkpoint inhibitors and their role in cancer treatment. They explore the types of tumors eligible for these inhibitors, the management of adverse events, and the importance of cortisol replacement before thyroid replacement in central hypopositis. The speakers also explain the significance of Tumor Proportion Score as a biomarker for predicting response to immune checkpoint inhibitors.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 4min
Types of Tumors, Eligibility, and Differences Between Immunotherapy and Chemotherapy
04:09 • 4min
Classification and Grading of Adverse Events in Immunotherapy
07:49 • 10min
The Importance of Cortisol Replacement Before Thyroid Replacement in Central Hypopositis
17:50 • 8min
Understanding Tumor Proportion Score and Immune Checkpoint Inhibitors
25:59 • 4min